(Q43021340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

title

Oral pregabalin as an add-on treatment for status epilepticus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

Jan Novy

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Jan Novy

series ordinal

1

1 reference

12 November 2017

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

volume

51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

2207-2210

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20550551%20AND%20SRC:MED&resulttype=core&format=json

Pregabalin pharmacology and its relevance to clinical practice

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Is this patient dead, vegetative, or severely neurologically impaired? Assessing outcome for comatose survivors of cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Intravenous lacosamide as successful treatment for nonconvulsive status epilepticus after failure of first-line therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Refractory status epilepticus: a prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Rapid onset of seizure suppression with pregabalin adjunctive treatment in patients with partial seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

Determinants of success in the use of oral levetiracetam in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X

The use of topiramate in refractory status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2010.02646.X